BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1152354)

  • 1. [Comparison of digitoxin bioavailability from tablets and elixir during maintenance therapy (author's transl)].
    Ochs H; Bodem G; Hahn E; Dengler HJ
    Klin Wochenschr; 1975 May; 53(9):425-9. PubMed ID: 1152354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological availability of diagoxin in patients with or without gastric resection (Billroth II) (author's transl)].
    Ochs H; Bodem G; Kodrat G; Savic B; Baur MP
    Dtsch Med Wochenschr; 1975 Nov; 100(47):2430-4. PubMed ID: 810339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of the biological availability of lanatoside C and digoxin in long-term tests].
    Bodem G; Ochs H; Hahn E; Dengler HJ
    Schweiz Med Wochenschr; 1977 May; 107(19):658-66. PubMed ID: 867012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin tablet bioavailability: single-dose and steady-state assessment.
    Preibisz JJ; Butler VP; Lindenbaum J
    Ann Intern Med; 1974 Oct; 81(4):469-74. PubMed ID: 4412826
    [No Abstract]   [Full Text] [Related]  

  • 5. Maximal bioavailability of digoxin from tablets and oral solution in steady state.
    Manninen V; Reissell P; Ojala K
    Acta Med Scand; 1976; 199(6):487-9. PubMed ID: 937075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalent bioavailability from digoxin elixir and rapid-dissolution tablets.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    JAMA; 1974 Sep; 229(13):1774-6. PubMed ID: 4479121
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioavailability of digoxin tablets and elixir in the fasting and postprandial states.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    Clin Pharmacol Ther; 1974 Sep; 16(3):444-8. PubMed ID: 4412196
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biological availability of digoxin and beta-acetyldigoxin after single-dose administration (author's transl)].
    Clasen R; Kemmeter H; Gilfrich HJ
    Dtsch Med Wochenschr; 1979 Apr; 104(15):543-6. PubMed ID: 436626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption of beta-methyl-digoxin determined after a single dose and under steady state conditions.
    Boerner D; Olcay A; Schaumann W; Weiss W
    Eur J Clin Pharmacol; 1976 Feb; 9(4):307-14. PubMed ID: 971714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of the absolute bioavailability of four oral digoxin preparations (author's transl)].
    Rietbrock N; Alken RG; Ebert W
    Arzneimittelforschung; 1979; 29(11):1742-5. PubMed ID: 583489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the biologic availability of digoxin in man.
    Fleckenstein L; Kroening B; Weintraub M
    Clin Pharmacol Ther; 1974 Sep; 16(3):435-43. PubMed ID: 4606249
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioavailability of digoxin in man after oral administration of preparations with different dissolution rate.
    Nyberg L
    Acta Pharmacol Toxicol (Copenh); 1977; 40 Suppl 3():1-48. PubMed ID: 301340
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study on digoxin tablets with high bioavailability (author's transl)].
    Flasch CI; Heinz N
    Arzneimittelforschung; 1979; 29(6):961-4. PubMed ID: 582792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation.
    Bochner F; Huffman DH; Shen DD; Azarnoff DL
    J Pharm Sci; 1977 May; 66(5):644-7. PubMed ID: 874745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
    Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
    Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gycoside serum concentrations under maintenance therapy with Lanicor, Card-Lamuran, MF708d, and Lanitop (author's transl)].
    Weiss W; Olcay A; Teufel W; Glocke M
    Med Klin; 1975 Aug; 70(35):1367-74. PubMed ID: 809651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digitalis therapy in renal failure with special regard to digitoxin.
    Vöhringer HF; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):175-84. PubMed ID: 7021432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intersubject variation in absorption of digoxin in normal volunteers.
    Huffman DH; Manion CV; Azarnoff DL
    J Pharm Sci; 1975 Mar; 64(3):433-7. PubMed ID: 1151628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of digoxin bioavailability in single-dose studies.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    N Engl J Med; 1973 Sep; 289(13):651-4. PubMed ID: 4727968
    [No Abstract]   [Full Text] [Related]  

  • 20. [Enhanced bioavailability of digoxin from silica matrix formulations (author's transl)].
    Flasch H; Asmussen B; Heinz N
    Arzneimittelforschung; 1978; 28(2):326-30. PubMed ID: 205226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.